|
|
|
No further submissions are being accepted for this event.
Agenda Topics:
- Reviews of Company Pipelines
- Clinical Trial Status of Nucleic Acid-Based Therapeutics
- Patent Status of Nucleic Acid-Based Diagnostics and Therapeutics
- Nucleic Acid Drug Delivery
- microRNAs as Diagnostics and Therapeutic Entities
- Nucleic Acid Biomarkers for Personalized Medicine
- Reimbursement and Regulatory Landscape
- Investor Attitudes to this Sector
- Emerging Company Showcase
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility of the content of the abstract and we assume that all co-authors are aware of this content. Please note that your biography, summary and abstract may be used on this website and conference materials.
Please send any queries to: h.read@selectbiosciences.com |